Advertisement
Screener

Alkermes plc. (ALKS) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

2.3 / 5 stars · 41/89 Roast Me

Alkermes plc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Alkermes plc. (ALKS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.75 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-07-28

  • Alkermes plc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 5.75M shares, a 53.64% decline year-over-year.
  • Alkermes plc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 13.55M shares, a 9.20% increase year-over-year.
  • Alkermes plc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 11.69M shares, a 5.15% decline year-over-year.
  • Alkermes plc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 12.41M shares, a 26.22% decline year-over-year.
  • Alkermes plc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 11.71M shares, a 15.80% decline from fiscal 2024.
  • Alkermes plc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 13.91M shares, a 6.03% decline from fiscal 2023.
  • Alkermes plc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 14.80M shares, a 16.93% decline from fiscal 2022.
  • Alkermes plc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 17.82M shares, a 19.06% increase from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-305.75M shares
10-Q · filed 2026-07-28
13.04M shares
10-Q · filed 2026-07-28
2026-03-3113.55M shares
10-Q · filed 2026-05-05
2025-12-3111.71M shares
10-K · filed 2026-02-25
2025-09-3011.69M shares
10-Q · filed 2025-10-28
12.29M shares
10-Q · filed 2025-10-28
2025-06-3012.41M shares
10-Q · filed 2025-07-29
11.30M shares
10-Q · filed 2026-07-28
2025-03-3112.41M shares
10-Q · filed 2026-07-28
7.96M shares
10-Q · filed 2025-05-01
2024-12-3113.91M shares
10-K · filed 2026-02-25
2024-09-3012.32M shares
10-Q · filed 2025-10-28
14.71M shares
10-Q · filed 2025-10-28
2024-06-3016.81M shares
10-Q · filed 2025-07-29
14.85M shares
10-Q · filed 2025-07-29
2024-03-3112.93M shares
10-Q · filed 2025-05-01
2023-12-3114.80M shares
10-K · filed 2026-02-25
2023-09-3013.35M shares
10-Q · filed 2024-10-24
14.81M shares
10-Q · filed 2024-10-24
2023-06-3013.32M shares
10-Q · filed 2024-07-24
15.31M shares
10-Q · filed 2024-07-24
2023-03-3119.10M shares
10-Q · filed 2024-05-01
2022-12-3117.82M shares
10-K · filed 2025-02-12
2022-09-3017.95M shares
10-Q · filed 2023-10-25
18.24M shares
10-Q · filed 2023-10-25
2022-06-3017.50M shares
10-Q · filed 2023-07-26
18.93M shares
10-Q · filed 2023-07-26
2022-03-3119.42M shares
10-Q · filed 2023-04-26
2021-12-3114.96M shares
10-K · filed 2024-02-21
18.77K shares
10-K · filed 2022-02-16
2021-09-3016.54M shares
10-Q · filed 2022-11-02
18.88M shares
10-Q · filed 2022-11-02
2021-06-3016.06M shares
10-Q · filed 2022-07-27
18.45M shares
10-Q · filed 2022-07-27
2021-03-3118.33M shares
10-Q · filed 2022-04-27
18.33K shares
10-Q · filed 2021-04-28
2020-12-3118.55M shares
10-K · filed 2023-02-16
18.55K shares
10-K · filed 2021-02-11
2020-09-3017.67M shares
10-Q · filed 2021-10-27
17.67K shares
10-Q · filed 2020-10-29
19.03M shares
10-Q · filed 2021-10-27
19.03K shares
10-Q · filed 2020-10-29
2020-06-3021.57M shares
10-Q · filed 2021-07-28
21.57K shares
10-Q · filed 2020-07-29
19.60M shares
10-Q · filed 2021-07-28
19.60K shares
10-Q · filed 2020-07-29
2020-03-3119.25K shares
10-Q · filed 2021-04-28
2019-12-3116.99K shares
10-K · filed 2022-02-16
2019-09-3017.21K shares
10-Q · filed 2020-10-29
17.21M shares
10-Q · filed 2019-10-23
17.19K shares
10-Q · filed 2020-10-29
17.19M shares
10-Q · filed 2019-10-23
2019-06-3017.80K shares
10-Q · filed 2020-07-29
17.80M shares
10-Q · filed 2019-07-25
16.83K shares
10-Q · filed 2020-07-29
16.83M shares
10-Q · filed 2019-07-25
2019-03-3114.75K shares
10-Q · filed 2020-04-29
14.75M shares
10-Q · filed 2019-04-25
2018-12-3113.92K shares
10-K · filed 2021-02-11
13.92M shares
10-K · filed 2019-02-15
2018-09-3014.23M shares
10-Q · filed 2019-10-23
12.89M shares
10-Q · filed 2019-10-23
2018-06-3014.40M shares
10-Q · filed 2019-07-25
13.28M shares
10-Q · filed 2019-07-25
2018-03-3113.03M shares
10-Q · filed 2019-04-25
2017-12-3111.66K shares
10-K · filed 2020-02-13
11.66M shares
10-K · filed 2018-02-16
2017-09-3011.77M shares
10-Q · filed 2018-10-23
11.62M shares
10-Q · filed 2018-10-23
2017-06-3012.01M shares
10-Q · filed 2018-07-26
11.51M shares
10-Q · filed 2018-07-26
2017-03-3111.01M shares
10-Q · filed 2018-04-26
2016-12-3111.49M shares
10-K · filed 2019-02-15
2016-09-3010.50M shares
10-Q · filed 2017-10-26
11.75M shares
10-Q · filed 2017-10-26
2016-06-3012.54M shares
10-Q · filed 2017-07-27
11.76M shares
10-Q · filed 2017-07-27
2016-03-3111.27M shares
10-Q · filed 2017-04-27
2015-12-3110.53M shares
10-K · filed 2018-02-16
2015-09-3011.02M shares
10-Q · filed 2016-11-02
10.95M shares
10-Q · filed 2016-11-02
2015-06-3011.77M shares
10-Q · filed 2016-07-28
11.34M shares
10-Q · filed 2016-07-28
2015-03-3110.94M shares
10-Q · filed 2016-04-28
2014-12-3111.09M shares
10-K · filed 2017-02-17
2014-09-3011.40M shares
10-Q · filed 2015-10-29
11.43M shares
10-Q · filed 2015-10-29
2014-06-302.57M shares
10-Q · filed 2015-07-30
11.54M shares
10-Q · filed 2015-07-30
2014-03-3111.11M shares
10-Q · filed 2015-04-30
2013-12-311.40M shares
10-K · filed 2016-02-25
2013-09-3010.47M shares
10-Q · filed 2013-10-31
10.22M shares
10-Q · filed 2013-10-31
1.08M shares
10-Q · filed 2014-10-29
2013-06-30883.00K shares
10-Q · filed 2014-07-31
516.00K shares
10-Q · filed 2014-07-31
2013-03-3110.47M shares
10-Q · filed 2014-10-29
2.08M shares
10-Q · filed 2014-04-30
4.50M shares
10-K · filed 2015-02-24
2012-12-314.57M shares
10-Q · filed 2013-01-31
5.79M shares
10-Q · filed 2013-01-31
2012-09-3011.22M shares
10-Q · filed 2013-10-31
6.47M shares
10-Q · filed 2013-10-31
2012-06-306.17M shares
10-Q · filed 2013-07-25
2012-03-319.50M shares
10-K · filed 2013-05-23
2011-12-3110.20M shares
10-Q · filed 2013-01-31
9.80M shares
10-Q · filed 2013-01-31
2011-09-309.54M shares
10-Q · filed 2012-11-01
9.63M shares
10-Q · filed 2012-11-01
2011-06-309.43M shares
10-Q · filed 2012-07-26
2011-03-319.50M shares
10-KT · filed 2014-02-27
14.29M shares
10-K · filed 2012-05-18
2010-03-3118.09M shares
10-K · filed 2012-05-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76